ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Marker Therapeutics (MRKR) Technical (Analysis) Reports Marker Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Marker Therapeutics (MRKR)

Technical Analysis Report for NASDAQ stock MRKR Marker Therapeutics. Dated: 05 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock MRKR Marker Therapeutics then click here. or read Experts views on Marker Therapeutics or Forecast & share price targets of Marker Therapeutics

Marker Therapeutics Opened at 1.42 and Closed at: 1.32, which is -7.58% of previous session's close. It moved within a range of 1.31 and 1.43
The session was a Bearish session with an average volume of 353500, which is -34.17% of previous session's volumes.

  • Even though the stock has fallen, but its short term trend is positive and in an uptrend.
  • Even though the stock has fallen, but its mid term trend is positive and in an uptrend.

A Golden cross was found 9 days back on mid term averages

Support for tomorrow is 1.26 and resistance for tomorrow is 1.38
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 1.28, 1.23 resistance for tomorrow's hourly charts is 1.4, 1.47

10 Day SMA for Marker Therapeutics (MRKR) is 1.21 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Marker Therapeutics (MRKR) is 1.08 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Marker Therapeutics (MRKR) is 1.03 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 1.1 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Marker Therapeutics is 1.22 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Marker Therapeutics is at 1.08 and 200 DMA is at 1.22, while 50 DMA and 100 DMA are at 1.03 and 1.1 respectively

Marker Therapeutics (MRKR) moving average of 20 SMA is at 1.08 and 20 EMA is at 1.13

Marker Therapeutics (MRKR) moving average of 50 SMA is at 1.03 and 50 EMA is at 1.08

Marker Therapeutics (MRKR) moving average of 100 SMA is at 1.1 and 100 EMA is at 1.17

Marker Therapeutics (MRKR) moving average of 200 SMA is at 1.22 and 200 EMA is at 1.42

Marker Therapeutics has performed better than Tonix Pharmaceuticals in short term. Holding Marker Therapeutics could be a better choice for now!

Marker Therapeutics has performed better than Pulmatrix Inc in short term. Holding Marker Therapeutics could be a better choice for now!

Marker Therapeutics has performed better than Puma Biotechnology in short term. Holding Marker Therapeutics could be a better choice for now!

Marker Therapeutics has performed better than Oramed Pharmaceuticals in short term. Holding Marker Therapeutics could be a better choice for now!

Marker Therapeutics has performed better than Novavax Inc in short term. Holding Marker Therapeutics could be a better choice for now!

Marker Therapeutics has performed better than Intellia Therapeutics in short term. Holding Marker Therapeutics could be a better choice for now!

Marker Therapeutics has performed better than Krystal Biotech in short term. Holding Marker Therapeutics could be a better choice for now!

Marker Therapeutics has performed better than Achieve Life in short term. Holding Marker Therapeutics could be a better choice for now!

Marker Therapeutics has performed better than Addus Homecare in short term. Holding Marker Therapeutics could be a better choice for now!

Marker Therapeutics has performed better than Adverum Biotechnologies in short term. Holding Marker Therapeutics could be a better choice for now!

Marker Therapeutics has performed better than Alkermes Plc in short term. Holding Marker Therapeutics could be a better choice for now!

Marker Therapeutics has performed better than Anixa Biosciences in short term. Holding Marker Therapeutics could be a better choice for now!

Marker Therapeutics has performed better than Accuray Incorporated in short term. Holding Marker Therapeutics could be a better choice for now!

Marker Therapeutics has performed better than Autolus Therapeutics in short term. Holding Marker Therapeutics could be a better choice for now!

Marker Therapeutics has performed better than Capnia Inc in short term. Holding Marker Therapeutics could be a better choice for now!

Marker Therapeutics has performed better than Dariohealth Corp in short term. Holding Marker Therapeutics could be a better choice for now!

Marker Therapeutics has performed better than Eton Pharmaceuticals in short term. Holding Marker Therapeutics could be a better choice for now!

Marker Therapeutics has performed better than Halozyme Therapeutics in short term. Holding Marker Therapeutics could be a better choice for now!

Marker Therapeutics Technical analysis of indicators

Price action analysis of Marker Therapeutics (MRKR) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Marker Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Marker Therapeutics in short term and the buy signal is strong.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Marker Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down

CCI has generated a buy signal for Marker Therapeutics in short term and BUY signal is strong.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Marker Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 1.23 and Marker Therapeutics MRKR stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Marker Therapeutics MRKR stock. Volume based technical analysis of Marker Therapeutics MRKR stock is negative.

Marker Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock MRKR Marker Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And MRKR Experts View which covers a lot of information including buying and selling signals

MRKR future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Marker Therapeutics or View Candle Stick Charts here

Chart Marker Therapeutics (MRKR)  Technical (Analysis) Reports Marker Therapeutics [

Videos related to: Marker Therapeutics (MRKR) Technical (Analysis) Reports Marker Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Marker Therapeutics (MRKR)  Technical (Analysis) Reports Marker Therapeutics [

 

Back to top